Soligenix Inc (SNGX)
0.423
+0.02
(+3.80%)
USD |
NASDAQ |
May 03, 11:25
Soligenix Max Drawdown (5Y): 99.24% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.24% |
March 31, 2024 | 99.21% |
February 29, 2024 | 99.21% |
January 31, 2024 | 99.21% |
December 31, 2023 | 99.21% |
November 30, 2023 | 99.21% |
October 31, 2023 | 99.13% |
September 30, 2023 | 99.13% |
August 31, 2023 | 99.12% |
July 31, 2023 | 98.75% |
June 30, 2023 | 98.68% |
May 31, 2023 | 98.58% |
April 30, 2023 | 97.41% |
March 31, 2023 | 97.32% |
February 28, 2023 | 97.32% |
January 31, 2023 | 97.32% |
December 31, 2022 | 97.32% |
November 30, 2022 | 97.32% |
October 31, 2022 | 97.32% |
September 30, 2022 | 97.32% |
August 31, 2022 | 97.32% |
July 31, 2022 | 97.32% |
June 30, 2022 | 97.32% |
May 31, 2022 | 97.32% |
April 30, 2022 | 97.32% |
Date | Value |
---|---|
March 31, 2022 | 97.32% |
February 28, 2022 | 97.32% |
January 31, 2022 | 97.32% |
December 31, 2021 | 97.32% |
November 30, 2021 | 97.32% |
October 31, 2021 | 97.32% |
September 30, 2021 | 97.32% |
August 31, 2021 | 97.32% |
July 31, 2021 | 97.32% |
June 30, 2021 | 97.32% |
May 31, 2021 | 97.32% |
April 30, 2021 | 97.32% |
March 31, 2021 | 97.32% |
February 28, 2021 | 97.32% |
January 31, 2021 | 97.32% |
December 31, 2020 | 97.32% |
November 30, 2020 | 97.32% |
October 31, 2020 | 97.32% |
September 30, 2020 | 97.32% |
August 31, 2020 | 97.32% |
July 31, 2020 | 97.32% |
June 30, 2020 | 97.32% |
May 31, 2020 | 97.32% |
April 30, 2020 | 97.32% |
March 31, 2020 | 97.32% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.30%
Minimum
May 2019
99.24%
Maximum
Apr 2024
97.67%
Average
97.32%
Median
Jun 2019
Max Drawdown (5Y) Benchmarks
Eagle Pharmaceuticals Inc | 93.70% |
Marinus Pharmaceuticals Inc | 94.98% |
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -72.21 |
Beta (5Y) | 1.928 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.96% |
Historical Sharpe Ratio (5Y) | -0.5231 |
Historical Sortino (5Y) | -1.005 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 44.34% |